Soleil Securities
http://www.soleilgroup.com/index.shtmlSoleil Securities provides equity research for institutional investors.
-
Soleil Securities Calls Savient Pharmaceuticals (SVNT) CEO Search An Important Step in the Right Direction
-
Notable Analyst Rating Changes 11/08: INTC, CVH, ROSE, SVNT Upgraded; CLWR, ALU, SWKS, PLAB Downgraded
-
Soleil Securities Upgrades Savient Pharmaceuticals (SVNT) to Buy; Lowering Krystexxa Estimates, but SVNT is Oversold
-
Soleil Downgrades Savient Pharma (SVNT) to Hold; Sees Limited Upside Despite Possible M&A Activity
-
Savient (SVNT): FDA Approval "Check", M&A Next
-
Soleil Securities Initiates Coverage on Savient Pharmaceuticals (SVNT) with a Buy
